OBJECTIVES Orthostatic hypotension (OH) is an independent risk factor for cardiovascular morbidity. It is often unrecognized in the elderly. Given the impact of OH, it would seem important to identify it in clinical practice. The association between central hemodynamic indices (e.g. central systolic blood pressure, augmentation index and pulse wave velocity) and OH is unclear. This study evaluates whether central hemodynamic indices are correlated with OH and tests the usefulness of central hemodynamic indices to identifying OH.
OBJECTIVES Both bisoprolol and metoprolol sustained release tablet (SR) are indicated in the management of hypertension. While long duration of effect in metoprolol SR was achieved through its sustained-release formulation, bisoprolol has intrinsic long duration of action. This study aimed to investigate long action of bisoprolol compared with metoprolol SR in controlling mean dynamic heart rate and diastolic blood pressure in the last 4 hours of a 12-week treatment period in patients with mild-to-moderate primary hypertension.
METHODS 186 mild-to-moderate hypertensive patients from 7 centers in China were enrolled in this randomized, parallel, multicenter, open-label clinical study from Dec 2011 to Dec 2014. Patients were treated with either bispoprolol 5-10 mg or metoprolol SR 47.5-95 mg once daily for 12 weeks. Primary end points were mean dynamic heart rate control and mean dynamic diastolic blood pressure control in the last 4 hours of the treatment period. Secondary endpoints included ambulatory monitoring of the blood pressure and heart rate, safety, and compliance.
RESULTS A total of 186 subjects were enrolled and analyzed, 93 subjects in each group respectively. In the last 4 hours of the treatment period, bisoprolol demonstrated significantly better control of mean dynamic heart rate compared with metoprolol SR (LSmeans difference: -3.79 bpm,97.5% CI: -7.45, -0.14). In the last 4 hours of the treatment period, the LSmeans difference of diastolic blood pressure was -1.00 (97.5% CI: -4.79, 2.78), with the upper limit less than 4, indicating that bisoprolol group was noninferior to metoprolol sustained release tablets group bisoprolol further provided significantly better control in 24 hour mean ambulatory, mean daytime, and nighttime heart rate. The overall adverse event (AE) rate was similar in bisoprolol group and metoprolol SR group (20.43% vs 17.20%). Noncompliance was reported in 3(3.53%) and 6(7.32%) subjects in bisoprolol and metoprolol sustained release tablets group respectively.
CONCLUSIONS Both bisoprolol and metoprolol SR could have long action. Bisoprolol provided superior dynamic heart rate control and noninferior dynamic blood pressure control vs metoprolol SR in patients with mild-to-moderate hypertension. No new safety concern was found.
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A novel relationship between reverse-dipper pattern of blood pressure and type 2 diabetes in hypertensive patients Bin Yan, 1 Lu Sun, 2 Dan Su, 3 Liyuan Peng, 1 Gang Wang 1 1 Department of Emergency Medicine, the Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China; 2 Department of Ultrasound, the Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China; 3 Department of Cardiology, the Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China OBJECTIVES Nocturnal variations of blood pressure (BP) were associated with type 2 diabetes. However, the relationship between the reverse-dipper pattern of BP and type 2 diabetes remains unknown.
METHODS
In this cross-sectional study, BP variations of 531 hypertensive patients (285 men, 246 women) were evaluated with ambulatory blood pressure monitoring (ABPM). Circadian BP patterns were then divided into dipper (10% to 20% SBP fall), nondipper (0% to 10% SBP fall), extreme dipper (>20% SBP fall) and reverse dipper (SBP nocturnal rise), according to the nocturnal reduction of systolic blood pressure (SBP). All other hypertensive patients were excluded if they (1) were <18 or >90 years old; (2) were under antihypertensive treatment; (3) had a BP over 160/100 mmHg; (4) were night workers; (5) had acute stroke or myocardial infarction within the past 6 months; (6) had sleep apnea syndrome; (7) were diagnosed as secondary hypertension; (8) could not tolerate the ABPM; (9) had other chronic diseases. Diagnosis of type 2 diabetes was made according to the 2015 Standards of medical care in diabetes. Descriptive statistics are presented as percentages for discrete variables and as means (standard deviation) for continuous variables. Multivariate logistic regression was used to examine the relationship between type 2 diabetes and ABPM results.
RESULTS
In our study, a total of 133 patients (21.0%) had reversedipper BP pattern. Nondipper pattern was observed in 300 (47.5%) hypertensive individuals and dipper pattern in 98 patients (15.5%). Reverse dippers were older (P<0.05), while had a higher fasting glucose (P<0.05), SBP-(P<0.05) and DBP-bedtime (P<0.05). Importantly, the prevalence of diabetes (p<0.05) in reverse dippers was the highest among the patients of all BP patterns. After analysis of multivariate logistic regression, the reverse-dipper pattern of BP was shown to be directly associated with type 2 diabetes (Odds ratio [OR] 1.630; 95%CI 1.057-2.512; p¼0.027). Moreover, fasting glucose was negatively correlated with the decline rate of nocturnal SBP (r¼-0.128; p¼0.003) and DBP (r¼-0.125; p¼0.004). The result of our study also suggested that type 2 diabetes (OR 1.636; 95%CI 1.049-2.553; p¼0.030), age (OR 1.030; 95%CI 1.013-1.047; p¼0.030) and triglycerides (OR 1.247; 95%CI 1.010-1.539; p¼0.040) might contribute to the reverse-dipper pattern of BP.
CONCLUSIONS The reverse-dipper pattern of BP in ABPM may serve as one of the independent risk factors for type 2 diabetes. Therefore, more personalized BP control should be administered on the patients who had an elevated nocturnal BP.
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Plasma migration inhibitory factor as biomarker in hypertensionhyperlipidemia patients Zhou Boda, 1 Ren Chuan, 1 Zu Lingyun, 1 Zheng Lemin, 2 Guo Lijun, 1 Zhang Youyi, 1 Gao Wei 1 1 Department of Cardiology, Peking University Third Hospital; 2 The Institute of Cardiovascular Sciences and Institute of Systems Biomedicine, Peking University Health Science Center healthy subjects were enrolled as healthy control group(HEALTHY). The demographic, biochemical and clinical data as well as endothelial function was examined. Plasma MIF was measured using ELISA kits as described previously. In order to find the influencing factor of MIF, we performed correlation analysis between plasma MIF levels and clinical characteristics. To explore the functional significance of elevated plasma MIF in HTN-HLP patients, we treated HUVECs with pooled plasma of HTN-HLP and HEALTHY groups. The protein levels of adhesion molecules VCAM-1 and ICAM-1 were examined 6 hours after treatment.
RESULTS
We found that plasma MIF was significantly elevated in the HTN-HLP group comparing with HEALTHY group (65.60AE44.35pg/ml vs 26.63AE10.85pg/ml, p<0.001). Serum NO(nitric oxide) (19.10AE1.71nmol/ ml vs 33.82AE2.50nmol/ml, p<0.001) and eNOS(endothelial nitric oxide synthase) (17.68AE1.85U/ml vs 31.25AE2.77U/ml, p<0.001) levels were significantly lower in HTN-HLP group. Serum ET-1(endothelin-1) levels were significantly higher in HTN-HLP group comparing with HEALTHY group(95.44AE3.16pg/ml vs 43.15AE3.09pg/ml, p<0.001). Furthermore, in the combined population of HTN-HLP and HEALTHY groups, SBP(R 2 ¼0.198, p<0.001), DBP(R 2 ¼0.216, p<0.001), left baPWV(brachial-ankle pulse wave velocity) (R 2 ¼0.122, p¼0.007), right baPWV(R 2 ¼0.129, p¼0.005) and ET-1(R 2 ¼0.248, p<0.001) were significantly positively correlated with plasma MIF levels, NO(R 2 ¼-0.184, p<0.001) and eNOS (R 2 ¼-0.230, p<0.001) were significantly negatively correlated with plasma MIF levels. Plasma from HTN-HLP significantly stimulated VCAM-1(p¼0.002) and ICAM-1(p¼0.01) protein expression on the surface of HUVECs.
CONCLUSIONS Plasma MIF was elevated in HTN-HLP patients, and positively correlated with blood pressure and early atherosclerosis parameters, negatively correlated with endothelial function parameters. Plasma from HTN-HLP significantly stimulated adhesion molecules expression, MIF may act as biomarker for HTN-HLP patients.
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The relationship of retinal vessel diameters and fractal dimensions with blood pressure and cardiovascular risk factors 
METHODS
In this cross-sectional study, fundus photographs were collected and semi-automated analysis software was used to analyze retinal vessel diameters and fractal dimensions. Cardiovascular risk factors such as relevant medical history, blood pressure (BP), lipids, and blood glucose data were collected.
RESULTS Subjects had a mean age of 51.9612.0 years and included 812 (37.4%) males and 1,357 (62.6%) females. Of the subjects, 726 (33.5%) were overweight, 226 (10.4%) were obese, 272 (12.5%) had diabetes, 738 (34.0%) had hypertension, and 1,156 (53.3%) had metabolic syndrome. After controlling for the effects of potential confounders, multivariate analyses found that age (b ¼ 0.06, P ¼ 0.008), sex (b ¼ 1.33, P ¼ 0.015), mean arterial blood pressure (b ¼ -0.12, P<0.001), high-sensitivity C-reactive protein (b ¼ -0.22, P ¼ 0.008), and CRVE (b ¼ 0.23, P<0.001) were significantly associated with CRAE. Age (b ¼ -0.0012, P<0.001), BP classification (prehypertension: b ¼ -0.0075, P ¼ 0.014; hypertension: b ¼ -0.0131, P ¼ 0.002), and hypertension history (b ¼ -0.0007, P ¼ 0.009) were significantly associated with D(f).
CONCLUSIONS D(f) exhibits a stronger association with BP than CRAE. Thus, D(f) may become a useful indicator of cardiovascular risk.
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